Back

Interim results from MyCLIMB, a natural history study of pediatric MYBPC3-associated hypertrophic cardiomyopathy

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Paediatric cardiomyopathy Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Georgia Sarquella Brugada

Hospital Sant Joan de Deu, Barcelona (Spain)

6 More presentations in this session

Presentation thumbnail
Independent predictors of dismal and favourable outcome in adult and paediatric myocarditis: data from the multicentric Italian Rare Biopsy-proven Myocarditis Registry
Doctor A. Giordani (Padova, IT)
Abstract Slides Video
Presentation thumbnail
Analysis of risk factors and construction of predictive model for adverse outcomes of fulminant myocarditis in children
Professor B. Han (Jinan, CN)
Abstract Slides Video
Presentation thumbnail
Clinical characteristics of genetic and gene-elusive arrhythmogenic cardiomyopathy phenotypes in children.
Doctor S. Moscatelli (London, GB)
Abstract Slides Video
Presentation thumbnail
The yield of clinical screening in childhood relatives of individuals with gene-elusive hypertrophic cardiomyopathy
Doctor G. Norrish (London, GB) Professor J. Kaski (London, GB)
Abstract Slides Video
Presentation thumbnail
Sarcomere gene variants did not improve cardiac function in pediatric patients with dilated cardiomyopathy
Doctor K. Hirono (Toyama, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Paediatric cardiomyopathy

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Clinical characteristics of genetic and gene-elusive arrhythmogenic cardiomyopathy phenotypes in children.
thumbnail
Congress Presentation
Hypertrophic cardiomyopathy with the three Dutch founder variants in MYBPC3: a natural history and comparison
thumbnail
Congress Presentation
Founder novel mutations in hypertrophic cardiomyopathy patients in Italy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources